DBPR116 is a brain-penetrant prodrug of BPRMU191. When co-administered with Naltrexone, it demonstrates potent analgesic efficacy in preclinical models, including thermal and cancer pain, while showing a reduced side-effect profile compared to morphine, making it a promising candidate for safer opioid analgesic research.
Molekulargewicht:
359.42
CAS Nummer:
[2131200-75-2]
Formel:
C19H18FNO3S
Target-Kategorie:
Opioid Receptor
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
